AVE 0.00% 0.2¢ avecho biotechnology limited

marketing is the key to poh growth, page-35

  1. 5,821 Posts.
    lightbulb Created with Sketch. 338
    Yes GC, regarding OXYPatch, I have posed the scenario before that the oxy trials can be delayed to 1. save money until interbal cash flow is sufficient 2. enable the elixia projects time to bring in the money to fully fund Oxypatch all the way.

    But a deal may tentatively be in place?????

    There are several scenarios and options open.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.2¢
Change
0.000(0.00%)
Mkt cap ! $6.338M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
22 34784472 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 34738413 20
View Market Depth
Last trade - 16.12pm 14/10/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.